The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA analysis in patients with BRAF-mutated metastatic cutaneous melanoma treated with BRAF and MEK inhibitors: Analysis of the OPTIMEL study.
 
Alexandre Harle
Honoraria - AstraZeneca; Biocartis; GlaxoSmithKline; MSD Oncology; Pierre Fabre; SOPHiA Genetics
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Janssen Oncology; SOPHiA Genetics
 
Albane Marie Lhuillier
No Relationships to Disclose
 
Nassim Sahki
No Relationships to Disclose
 
Florence Granel Brocard
No Relationships to Disclose
 
Amélie Schoeffler
No Relationships to Disclose
 
Hélène Martin
No Relationships to Disclose
 
Philippe Muller
No Relationships to Disclose
 
Alice Hervieu
Consulting or Advisory Role - Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Novartis
 
Marie Rouyer
No Relationships to Disclose
 
Marie Husson
No Relationships to Disclose
 
Denise Bechet
No Relationships to Disclose
 
Magali Lefebvre
No Relationships to Disclose
 
Julien Scala Bertola
No Relationships to Disclose
 
Nicolas Gambier
No Relationships to Disclose
 
Allan Kolodziej
No Relationships to Disclose
 
Jean-Louis Merlin
Honoraria - Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Novartis; Pierre Fabre
Research Funding - Biocartis; Novartis
Travel, Accommodations, Expenses - Novartis; Pierre Fabre
 
Lionnel Geoffrois
Honoraria - BMS; Ipsen; Merck serono; MSD; Pfizer
Consulting or Advisory Role - Ipsen; Merck Serono
Travel, Accommodations, Expenses - Ipsen; Merck Serono; MSD Oncology